本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ascendis Pharma A/S

156.59
-0.6150-0.39%
成交量:24.83萬
成交額:3,851.20萬
市值:94.54億
市盈率:-24.88
高:159.03
開:157.14
低:150.89
收:157.20
資料載入中...
2019/03/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/12

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/03/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/12

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/02/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/11

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/01/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/28

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]